ZOETIS INC (ZTS) Fundamental Analysis & Valuation
NYSE:ZTS • US98978V1035
Current stock price
119.99 USD
+0.24 (+0.2%)
At close:
120 USD
+0.01 (+0.01%)
After Hours:
This ZTS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZTS Profitability Analysis
1.1 Basic Checks
- In the past year ZTS was profitable.
- ZTS had a positive operating cash flow in the past year.
- ZTS had positive earnings in each of the past 5 years.
- ZTS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 17.28%, ZTS belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
- With an excellent Return On Equity value of 80.25%, ZTS belongs to the best of the industry, outperforming 99.48% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 21.95%, ZTS belongs to the top of the industry, outperforming 97.40% of the companies in the same industry.
- ZTS had an Average Return On Invested Capital over the past 3 years of 22.23%. This is significantly above the industry average of 13.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROIC | 21.95% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
1.3 Margins
- ZTS has a better Profit Margin (28.23%) than 93.75% of its industry peers.
- ZTS's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 38.54%, ZTS belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
- In the last couple of years the Operating Margin of ZTS has grown nicely.
- ZTS has a better Gross Margin (71.89%) than 78.13% of its industry peers.
- In the last couple of years the Gross Margin of ZTS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% |
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
2. ZTS Health Analysis
2.1 Basic Checks
- ZTS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- ZTS has less shares outstanding than it did 1 year ago.
- ZTS has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ZTS has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.49 indicates that ZTS is not in any danger for bankruptcy at the moment.
- The Altman-Z score of ZTS (5.49) is better than 77.08% of its industry peers.
- ZTS has a debt to FCF ratio of 3.96. This is a good value and a sign of high solvency as ZTS would need 3.96 years to pay back of all of its debts.
- ZTS has a Debt to FCF ratio of 3.96. This is amongst the best in the industry. ZTS outperforms 86.46% of its industry peers.
- A Debt/Equity ratio of 2.71 is on the high side and indicates that ZTS has dependencies on debt financing.
- ZTS has a worse Debt to Equity ratio (2.71) than 80.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Altman-Z | 5.49 |
ROIC/WACC2.49
WACC8.81%
2.3 Liquidity
- A Current Ratio of 3.03 indicates that ZTS has no problem at all paying its short term obligations.
- ZTS's Current ratio of 3.03 is in line compared to the rest of the industry. ZTS outperforms 52.60% of its industry peers.
- A Quick Ratio of 1.94 indicates that ZTS should not have too much problems paying its short term obligations.
- ZTS's Quick ratio of 1.94 is in line compared to the rest of the industry. ZTS outperforms 44.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 |
3. ZTS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 8.45% over the past year.
- The Earnings Per Share has been growing by 10.77% on average over the past years. This is quite good.
- ZTS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.28%.
- ZTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.24% yearly.
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
3.2 Future
- Based on estimates for the next years, ZTS will show a small growth in Earnings Per Share. The EPS will grow by 7.80% on average per year.
- ZTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.30% yearly.
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ZTS Valuation Analysis
4.1 Price/Earnings Ratio
- ZTS is valuated rather expensively with a Price/Earnings ratio of 18.69.
- Based on the Price/Earnings ratio, ZTS is valued cheaper than 83.85% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.91, ZTS is valued a bit cheaper.
- ZTS is valuated correctly with a Price/Forward Earnings ratio of 16.95.
- Based on the Price/Forward Earnings ratio, ZTS is valued cheaper than 82.81% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ZTS to the average of the S&P500 Index (23.68), we can say ZTS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.69 | ||
| Fwd PE | 16.95 |
4.2 Price Multiples
- 83.33% of the companies in the same industry are more expensive than ZTS, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZTS indicates a rather cheap valuation: ZTS is cheaper than 84.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.19 | ||
| EV/EBITDA | 13.87 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of ZTS may justify a higher PE ratio.
PEG (NY)1.82
PEG (5Y)1.74
EPS Next 2Y8.92%
EPS Next 3Y8.7%
5. ZTS Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.64%, ZTS has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.64, ZTS pays a better dividend. On top of this ZTS pays more dividend than 91.15% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, ZTS has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
5.2 History
- The dividend of ZTS is nicely growing with an annual growth rate of 20.56%!
- ZTS has paid a dividend for at least 10 years, which is a reliable track record.
- ZTS has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)20.56%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
- 33.26% of the earnings are spent on dividend by ZTS. This is a low number and sustainable payout ratio.
- The dividend of ZTS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.26%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
ZTS Fundamentals: All Metrics, Ratios and Statistics
119.99
+0.24 (+0.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12 2026-02-12/bmo
Earnings (Next)04-30 2026-04-30/bmo
Inst Owners100.79%
Inst Owner Change-0.01%
Ins Owners0.07%
Ins Owner Change3.93%
Market Cap50.65B
Revenue(TTM)9.47B
Net Income(TTM)2.67B
Analysts76.8
Price Target150.27 (25.24%)
Short Float %3.73%
Short Ratio3.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.64% |
Yearly Dividend2.04
Dividend Growth(5Y)20.56%
DP33.26%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-20 2026-04-20 (0.53)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.16%
Min EPS beat(2)3.79%
Max EPS beat(2)4.53%
EPS beat(4)4
Avg EPS beat(4)5.31%
Min EPS beat(4)3.79%
Max EPS beat(4)7.75%
EPS beat(8)8
Avg EPS beat(8)4.82%
EPS beat(12)10
Avg EPS beat(12)3.31%
EPS beat(16)12
Avg EPS beat(16)3.06%
Revenue beat(2)1
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-1.44%
Max Revenue beat(2)0.13%
Revenue beat(4)3
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-1.44%
Max Revenue beat(4)1.11%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.2%
PT rev (1m)-3.34%
PT rev (3m)-7.85%
EPS NQ rev (1m)0.01%
EPS NQ rev (3m)2.86%
EPS NY rev (1m)0%
EPS NY rev (3m)3.57%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.69 | ||
| Fwd PE | 16.95 | ||
| P/S | 5.35 | ||
| P/FCF | 22.19 | ||
| P/OCF | 17.44 | ||
| P/B | 15.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.87 |
EPS(TTM)6.42
EY5.35%
EPS(NY)7.08
Fwd EY5.9%
FCF(TTM)5.41
FCFY4.51%
OCF(TTM)6.88
OCFY5.73%
SpS22.43
BVpS7.89
TBVpS-1.03
PEG (NY)1.82
PEG (5Y)1.74
Graham Number33.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.28% | ||
| ROE | 80.25% | ||
| ROCE | 27.58% | ||
| ROIC | 21.95% | ||
| ROICexc | 26.6% | ||
| ROICexgc | 40.59% | ||
| OM | 38.54% | ||
| PM (TTM) | 28.23% | ||
| GM | 71.89% | ||
| FCFM | 24.12% |
ROA(3y)17.05%
ROA(5y)15.99%
ROE(3y)59.76%
ROE(5y)54.42%
ROIC(3y)22.23%
ROIC(5y)21.04%
ROICexc(3y)26.94%
ROICexc(5y)27.11%
ROICexgc(3y)44.63%
ROICexgc(5y)48.4%
ROCE(3y)27.92%
ROCE(5y)26.43%
ROICexgc growth 3Y-11.38%
ROICexgc growth 5Y-5.24%
ROICexc growth 3Y-2.74%
ROICexc growth 5Y2.7%
OM growth 3Y1.57%
OM growth 5Y2.33%
PM growth 3Y2.57%
PM growth 5Y2.85%
GM growth 3Y1.04%
GM growth 5Y0.73%
F-Score6
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.71 | ||
| Debt/FCF | 3.96 | ||
| Debt/EBITDA | 2.19 | ||
| Cap/Depr | 127.52% | ||
| Cap/Sales | 6.56% | ||
| Interest Coverage | 13.98 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 85.41% | ||
| Current Ratio | 3.03 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 5.49 |
F-Score6
WACC8.81%
ROIC/WACC2.49
Cap/Depr(3y)136.13%
Cap/Depr(5y)128.18%
Cap/Sales(3y)7.4%
Cap/Sales(5y)7.12%
Profit Quality(3y)82.33%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)8.45%
EPS 3Y9.57%
EPS 5Y10.77%
EPS Q2Q%5.71%
EPS Next Y10.25%
EPS Next 2Y8.92%
EPS Next 3Y8.7%
EPS Next 5Y7.8%
Revenue 1Y (TTM)2.28%
Revenue growth 3Y5.42%
Revenue growth 5Y7.24%
Sales Q2Q%3.02%
Revenue Next Year4.91%
Revenue Next 2Y4.88%
Revenue Next 3Y4.85%
Revenue Next 5Y5.3%
EBIT growth 1Y7.54%
EBIT growth 3Y7.08%
EBIT growth 5Y9.74%
EBIT Next Year18.93%
EBIT Next 3Y9.75%
EBIT Next 5Y8.5%
FCF growth 1Y-0.65%
FCF growth 3Y19.85%
FCF growth 5Y6.41%
OCF growth 1Y-1.66%
OCF growth 3Y14.95%
OCF growth 5Y6.44%
ZOETIS INC / ZTS Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ZOETIS INC (ZTS) stock?
ChartMill assigns a fundamental rating of 7 / 10 to ZTS.
Can you provide the valuation status for ZOETIS INC?
ChartMill assigns a valuation rating of 6 / 10 to ZOETIS INC (ZTS). This can be considered as Fairly Valued.
Can you provide the profitability details for ZOETIS INC?
ZOETIS INC (ZTS) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ZOETIS INC (ZTS) stock?
The Price/Earnings (PE) ratio for ZOETIS INC (ZTS) is 18.69 and the Price/Book (PB) ratio is 15.21.
What is the earnings growth outlook for ZOETIS INC?
The Earnings per Share (EPS) of ZOETIS INC (ZTS) is expected to grow by 10.25% in the next year.